Sudeep Pharma Ltd. (SUDEEPPHRM) Share Price Hits New 52-Week High
- August 6, 2026
- Posted by: Harsh Piplani
- Category: News
Sudeep Pharma Ltd. Share Price hits a new 52-week high at Rs 988.7, rising 2.02% today with a market cap of Rs 9,820.32 Cr.
Sudeep Pharma Ltd. Share Price has reached a new 52-week high of Rs 988.7, marking a 2.02% increase from the previous close of Rs 956.35. The company’s market capitalisation stands at Rs 9,820.32 crore, reflecting its significant presence in the healthcare sector. This milestone highlights the stock’s upward momentum, attracting attention from investors and analysts alike. The fresh 52-week high underscores the stock’s performance in the market, despite the absence of a specific catalyst in the supplied data. Investors are keenly observing the stock’s movement as it continues to gain traction in the market.
Sudeep Pharma Ltd. Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 975.7 |
| Previous Close | Rs 956.35 |
| Today's Change | +Rs 19.35 (+2.02%) |
| Day Open | Rs 980.3 |
| Fresh 52-Week High | Rs 988.7 |
| Day Low | Rs 945.25 |
| Current Volume | 20,759 |
| Turnover | Rs 2.03 crore |
| Market Capitalisation | Rs 9,820.32 crore |
Sudeep Pharma Ltd. (SUDEEPPHRM) traded at Rs 975.7. versus the previous close of Rs 956.35, a rise of 2.02%. The stock opened at Rs 980.3, reached Rs 988.7, touched Rs 945.25. Reported volume was 20,759.
Today, Sudeep Pharma Ltd. opened at Rs 980.3 and reached a high of Rs 988.7, setting a new 52-week peak. The stock’s low for the day was Rs 945.25, with a turnover of Rs 2.03 crore. The current volume of 20,759 shares indicates active participation, although the exact volume ratio compared to the average is not provided. The stock’s performance today is notable, as it surpassed its previous 52-week high, demonstrating strong market interest. This sets the stage for further analysis of the company’s fundamentals and sector positioning.
Sudeep Pharma Ltd. (SUDEEPPHRM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 9,820.32 crore |
| P/E Ratio | 31.4x |
| P/B Ratio | 0.46x |
| ROE | -2.89% |
| ROCE | -0.26% |
Sudeep Pharma Ltd. was valued at a P/E ratio of 31.4x, a P/B ratio of 0.46x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.
Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Benchmark Scope | same sector |
| Company P/E Ratio | 31.4x |
| Benchmark Median P/E | 21.61x |
| Benchmark Average P/E | 72.01x |
| Benchmark P/E Range | 0x to 3,428.55x |
| Company P/B Ratio | 0.46x |
| Benchmark Median P/B | 1.92x |
| Company ROE | -2.89% |
| Benchmark Median ROE | 10.75% |
| Company ROCE | -0.26% |
| Benchmark Median ROCE | 13.29% |
| Company Market Capitalisation | Rs 9,820.32 crore |
| Benchmark Median Market Cap | Rs 139.72 crore |
Sudeep Pharma Ltd. (SUDEEPPHRM) is classified under sector: Healthcare.
Sudeep Pharma Ltd. (SUDEEPPHRM) has a P/E ratio of 31.4x, which is above the benchmark median of 21.61x, a difference of +45.3%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Sudeep Pharma Ltd. (SUDEEPPHRM) has a ROE of -2.89%, which is below the benchmark median of 10.75%, a difference of -126.88%. Sudeep Pharma Ltd. (SUDEEPPHRM) has a ROCE of -0.26%, which is below the benchmark median of 13.29%, a difference of -101.96%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Dishman Carbogen Amcis Ltd. | DCAL | 2,943.6 | 31.4 | 0.46 | -2.89 | -0.26 |
| Kwality Pharmaceuticals Ltd. | KPL | 2,684.11 | 39.39 | 8.02 | 28.21 | 26.35 |
| Beta Drugs Ltd. | BETA | 2,621.81 | 63.25 | 10.01 | 18.65 | 22.17 |
| Dr Agarwals Eye Hospital Ltd. | DRAGARWQ | 2,511.89 | 32.96 | 6.79 | -2.6 | 16.92 |
| Sai Parenteral's Ltd. | SAIPARENT | 2,347.02 | 160.63 | 2.97 | 13.9 | 12.97 |
Sudeep Pharma Ltd. (SUDEEPPHRM) has a P/E ratio of 31.4x compared with the displayed peer median of 39.39x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 16.92%, providing a capital-efficiency comparison. Sudeep Pharma Ltd. (SUDEEPPHRM) has a market capitalisation of Rs 9,820.32 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
Why Investors Are Watching Sudeep Pharma Ltd.
- Reached a new 52-week high at Rs 988.7, indicating strong price momentum.
- Mixed fundamental signals with a low P/B ratio but negative ROE and ROCE.
- Significant market cap in the healthcare sector, above the sector median.
- Competitive P/E ratio compared to sector and peers.
About Sudeep Pharma Ltd.
Sudeep Pharma Ltd. operates within the healthcare sector, focusing on pharmaceuticals and related products. The company has established a substantial market presence with a market cap of Rs 9,820.32 crore. Despite its negative profitability metrics, it maintains a competitive P/E ratio, reflecting its potential for growth and market interest. The company’s operations and strategic positioning in the healthcare industry continue to attract investor attention.
Track Sudeep Pharma Ltd. Share Price on Univest
Use Sudeep Pharma Ltd. (SUDEEPPHRM) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Investors can track Sudeep Pharma Ltd. Share Price, technical indicators, fundamental ratios, shareholding patterns, 52-week levels, and market insights on Univest for comprehensive analysis and informed decision-making.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is the current share price of Sudeep Pharma Ltd.?
Ans. The current share price of Sudeep Pharma Ltd. is Rs 975.7, reflecting a 2.02% increase from the previous close. The stock moved 2.02% during the session. The intraday range extended from Rs 945.25 to Rs 988.7.
What is the 52-week high of Sudeep Pharma Ltd.?
Ans. Sudeep Pharma Ltd. has reached a new 52-week high of Rs 988.7, indicating strong market performance. The stock moved 2.02% during the session. The intraday range extended from Rs 945.25 to Rs 988.7.
How does Sudeep Pharma Ltd.'s P/E ratio compare to the sector?
Ans. Sudeep Pharma Ltd.'s P/E ratio of 31.4 is above the sector median of 21.61 but below the sector average of 72.01. The company trades at a P/E ratio of 31.4x.
What is the market capitalisation of Sudeep Pharma Ltd.?
Ans. The market capitalisation of Sudeep Pharma Ltd. is Rs 9,820.32 crore, reflecting its significant presence in the healthcare sector. The company operates in the Healthcare sector. Its P/E ratio is 31.4x.
How does Sudeep Pharma Ltd.'s P/B ratio compare to peers?
Ans. Sudeep Pharma Ltd.'s P/B ratio of 0.46 is notably lower than its peers, indicating a potentially undervalued position. The company trades at a P/E ratio of 31.4x. Its P/B ratio is 0.46x.
What are Sudeep Pharma Ltd.'s ROE and ROCE?
Ans. Sudeep Pharma Ltd. has a negative ROE of -2.89% and ROCE of -0.26%, indicating challenges in profitability and capital efficiency. ROE stands at -2.89%. ROCE stands at -0.26%. The relevant peer median ROE is 10.75%.
How does Sudeep Pharma Ltd. compare with Kwality Pharmaceuticals Ltd.?
Ans. Sudeep Pharma Ltd. has a lower P/E ratio and negative profitability metrics compared to Kwality Pharmaceuticals Ltd., which has a higher ROE and ROCE. Comparable listed companies include Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd., Beta Drugs Ltd.
What is the sector median market cap in healthcare?
Ans. The sector median market cap in healthcare is Rs 139.72 crore, significantly lower than Sudeep Pharma Ltd.'s market cap. The company operates in the Healthcare sector. Its P/E ratio is 31.4x.
